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Abstract
Purpose To evaluate the mid- to long-term results of the
Richards’ type II patellofemoral arthroplasty (PFA) in terms
of functional scores, number and type of complications, pa-
tient satisfaction and survival.
Methods We retrospectively studied patients that received a
Richards’ type II PFA at our institution between 1998 and
2007. Patients with a functioning PFA at the time of this study
were evaluated. Outcomes included survival rates with end-
point loss of prosthesis, number and type of complications,
Knee Society Scores (KSS) and Visual Analogue Scale (VAS)
for pain. In addition, patients were asked how surgery influ-
enced their original symptoms.
Results Twenty-four patients (33 prostheses) were included.
Follow-up ranged from 2.2 to 18.8 years with a mean of
9.7 years. Survival at 10 years was 73 % (95 % CI, 57–
93 %). Median KSS score was 163 (range, 110–200). Median
VAS Pain was 30 (range, 0–80) and VAS Satisfaction
median was 90 (range, 50–100). Thirteen (62 %) PFAs
were rated excellent, six (28 %) as good and two
(10 %) as fair. Twelve (36 %) of the cases required
further surgery within 4 years after implantation. Seven
of these (21 %) were converted to TKA after a mean time
of 5.5 years, five out of seven were converted because of
ongoing tibiofemoral osteoarthritis (TFOA).
Conclusions We found a rate of 21% (7/33) conversion of the
Richards’ II PFA to TKA after a mean of 5.5 years; 71 % (5/7)
of cases were because of TFOA.We strongly advise not to use
PFA if there is any sign of joint disease in other compartments
than patellofemoral.
Keywords Patellofemoral arthroplasty . Primary
arthroplasty . Cohort study . Patellofemoral
Introduction
Patellofemoral pain caused by isolated patellofemoral osteo-
arthritis (PFOA) is relatively common in general orthopaedic
practice. It has been reported that 3.8–8 % of knee pain due to
cartilage degeneration is caused by isolated PFOA [1, 2].
Patellofemoral arthroplasty (PFA) is a recognised treatment
option for end stage isolated patellofemoral osteoarthritis
(PFOA). The incidence in patients with knee pain in the pop-
ulation over 60 years old is approximately 15 % [1]. A strik-
ingly high percentage considering the percentage of PFA in all
knee prostheses is less than 1 % [3]. Apparently, despite the
theoretical advantage of PFA over total knee arthroplasty
(TKA) to treat only the involved compartment, TKA is more
commonly used for PFOA. Past results do favour TKA above
PFA, but newer implants seem to have improved PFA results.
Recently it has been reported that first-generation PFAs have a
higher likelihood of experiencing complications, re-operation,
or revision surgery than second-generation PFAs. Mechanical
complications were most commonly noted, followed by per-
sistent pain and on-going (tibiofemoral) osteoarthritis [4].
Although we recognised these problems associated with
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first-generation PFAs, we were not convinced that the
mentioned complications occurred in the same order and
magnitude in our cohort of first-generation Richards’ type II
PFAs.
To analyse this assumption, we conducted this study to
evaluate the mid- to long-term results of first-generation
Richards’ II PFAs performed in our centre in terms of func-
tional scores, number and type of complications, patient sat-
isfaction and survival. Survival was compared to the
Orthopaedic Data Evaluation Panel (ODEP) benchmark of
90 % survival rate at 10 years and with known data on the
Richards’ II PFA.
Patients and methods
We retrospectively studied patients that received a Richards’
type II PFA (Smith&NephewRichards, Memphis, TN, USA)
at our institution between 1998 and 2007. The Richards’ II
PFA has a particular constrained design with an inverted V-
shaped cobalt chromium trochlea and a V-shaped polyethyl-
ene patella button. Data were retrieved from our institutions’
databases. All patients were included consecutively. Our
Institutional Review Board approved this study and all inves-
tigations were conducted in conformity with the ethical prin-
ciples of research.
Surgical technique
Surgery was performed by a single surgeon. Antibiotic pro-
phylaxis was administered in all cases. The joint was
approached via a midline skin incision and medial parapatellar
arthrotomy, after which all compartments were assessed.
Sizing and placement was template assisted. Placement was
carried out to respect patellofemoral alignment, prevent im-
pingement of the anterior cruciate ligament distally and to
prevent overstuffing of the patellofemoral compartment.
Care was taken to reconstruct the position of the trochlear
groove and to prevent either of the flanges to become proud.
At the patellar side, patellar thickness was restored. Any part
of the lateral facet that remained uncovered was removed to
prevent impingement against the lateral femoral condyle or
trochlear prosthesis. Stability (tilting, subluxation, lateral
tightness), impingement and catching were tested over a full
range of motion and addressed before the definitive compo-
nents were cemented in place. Closure was done in a routine
fashion. All patients were allowed partial weight-bearing with
crutches from day 1. Physiotherapy was continued after dis-
charge if necessary. Since there were no contraindications, all
patients routinely received antithrombotic prophylaxis for
6 weeks.
Clinical follow-up and outcomes
Patients with a functioning PFA at the time of this study were
contacted and invited to our clinic for a clinical and radiolog-
ical post-operative evaluation of the knee(s).
We computed two survival rates with different endpoints:
loss of prosthesis (conversion to TKA or arthrodesis [AD])
and loss of integrity of the primary prosthesis (partial and full
revision). Other outcomes were number and type of compli-
cations, Knee Society Scores (KSS) [5] and Visual Analogue
Scale (VAS) for pain (0 = no pain, 100 = worst pain
imaginable) and satisfaction (0 = least satisfied, 100 =
most satisfied). As a benchmark for survival, the ODEP
criterion of 90 % survival at 10 years was used. In
addition, patients were asked how surgery influenced
their original symptoms. Each patient was asked to
score his/her own post-operative state into one of four
categories: (1) excellent, asymptomatic after PFA, (2)
good, improvement after PFA but not asymptomatic,
(3) fair, no change after PFA, or (4) poor, worse after
PFA.
Two recent radiographs of each PFA were evaluated for
signs of loosening and malpositioning. One of the authors
performed all radiographic evaluations and performed the
clinical examinations.
Statistical analysis
Descriptive statistics were used to summarise the data.
Dependent on distribution mean (SD) or median (range) were
used. The Kaplan-Meier product limited estimator method
was used for survival analysis. Patients that had died or were
lost to follow-up were censored. Survival data are presented as
percentage with 95 % confidence interval (CI). All analyses
were performed using SPSS 16.0 (SPSS IBM, Chicago, IL,
USA).
Results
Twenty-four patients (33 prostheses) were included. Nine pa-
tients (38 %) were operated bilaterally. Demographic data
showed a mean age at the time of surgery of 47.4 (32–81)
years, 5 (21 %) men and 19 (79 %) women, a mean BMI of
28.2 (19.6–42.85) and 16 left versus 17 right knees.
Indications for PFA included idiopathic patellofemoral osteo-
arthritis (21 PFAs, 64 %), secondary patellofemoral osteoar-
thritis (patellofemoral dysplasia and/or malalignment without
[sub]luxations) (10 PFAs, 30 %), secondary patellofemoral
osteoarthritis with instability (1 PFA, 3 %) and posttraumatic
osteoarthritis (1 PFA, 3 %).
For clinical follow-up, 21 of the 33 prosthesis were avail-
able; two patients (three PFAs) died due to PFA-unrelated
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causes, two patients (two PFAs) were not able to travel for
reasons not related to the implant and a further seven PFAs
were converted to TKA. Leaving a final total of 21 PFAs
available and eligible for clinical follow-up. Two patients in
this group had a functioning PFA on one side and a
(converted) TKA on the other. The number of clinical patients
followed-up was therefore 17, and not 15 as one might expect
if only unilateral cases were present.
Survival
Survival analysis of the 33 PFAs (24 patients) with loss of the
prosthesis (conversion to TKA or AD) as endpoint yielded a
73 % survival rate at 10 years (95 % CI, 57–93 %) (Fig. 1).
Survival rate when loss of integrity of the primary prosthesis
was defined as endpoint (partial and full revision) was 71% at
10 years (95 % CI, 55–91 %) (Fig. 2).
Clinical follow-up
Median follow-up was 6.1 years and ranged from 2.2 to
18.8 years. The median KSS score was 163 (range, 110–
200), VAS Pain 30 (range, 0–80) and VAS Satisfaction 90
(range, 50–100). Thirteen PFAs (62 %) were rated as excel-
lent, six (28%) as good and two (10%) as fair. All radiographs
at the time of the evaluation showed adequate positioning of
the PFA without any signs of loosening of the patellar or
femoral component.
Complications and re-operations
Twelve of the original 33 (36 %) PFAs had additional surgery
(Table 1). The indications for additional surgery varied. In five
of the 12 cases (15 % of all cases) ongoing tibiofemoral oste-
oarthritis (TFOA) was the main indication. Infection (n=1,
3 %), pain and/or stiffness (n=3, 9 %) and instability (n=3,
9 %) were the other indications. Seven PFAs were converted
to TKA after a mean time of 5.5 years (2.7–7.2 years), five out
of seven (71 %) because of TFOA.
In 28 surgical sessions, 31 additional procedures were per-
formed. Most of these procedures were sequential. The medi-
an time to the first post-operative procedure was 4 years and
4 months (range, 10 days to 11 years).
Some individual cases contributed significantly to the num-
ber of procedures as is shown in Table 1. Case numbers 5, 6
and 11R contributed 13 to the 31 (42 %) additional proce-
dures. Procedures prior to PFA implantation were also com-
mon; 33 knees underwent a total of 44 procedures. In Fig. 3
we present a chronological series of axial radiographs of a
troublesome case, which eventually was converted to TKA
(see also Table 1, case 5).
Discussion
We reported the mid- to long-term results of Richards’ II PFA
placed in our centre between 1998 and 2007 in terms of sur-
vival, functional scores, number and type of complications
and patient satisfaction. The survival with conversion to
Fig. 1 Survival rate according to
loss of the prosthesis (due to
conversion to TKA or AD)
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TKA as endpoint of 73 % (95 % CI, 57–93 %) at 10 years we
found in our study is, taking the confidence interval in to
consideration, comparable to published data on the
Richards’ II PFA, which varies from 75 % (surgery for any
reason, mean follow-up 10 [6–16] years) to approximately
84 % (conversion to TKA, mean follow-up 13 [2–31] years)
[6, 7]. The ODEP benchmark of 90 % survival at 10 years,
widely accepted as a minimal requirement for total hip and
knee arthroplasty, is not met, although 90 % is still within the
range of the confidence interval (57–93 %).
As mentioned in the introduction, the first genera-
tions of PFA experienced more complications than
newer designs [8]. Our re-operation rate of 36 % (12
out of 33) is higher than the 25 % reported by Dy et al.
[4]. In contrast, our patient satisfaction scores were good to
excellent in 90%, compared to 76–86% in the literature [3, 9].
In the literature, mechanical complications were most com-
monly noted, followed by persistent pain and ongoing
(tibiofemoral) osteoarthritis (TFOA) [4]. We saw the same
type of complications but in a different order. Most common
was TFOA (n=5, 15 %), followed by pain and/or stiffness
(n=3, 9 %), mechanical complications (instability) (n=3,
9 %) and (deep) infection (n=1, 3 %). We tried to
deduct if these re-interventions could have been prevented.
For the TFOA cases (Table 1: cases 1R, 4R, 1L, 9L and 11L)
there does not seem to be a causal relationship with the pri-
mary indication or previous surgery. In these cases further
surgery occurred 5.6–7.2 years after implantation. The infec-
tion case (Table 1: case 11R) was probably a low-grade infec-
tion from the start, becoming apparent at 1.5 years after
implantation with no apparent link with patients pre-
operative history. However, this case was re-operated on mul-
tiple times because of tracking issues. The number of proce-
dures are of course a risk factor for prosthetic joint in-
fection (PJI). The pain and stiffness cases (Table 1: cases
6, 8 and 9R) all seem to have a more elaborate history
that could influence the results of PFA, or any other type
of surgery for that matter. But again there does not seem
to be a direct causal link with patient history. Special
consideration should be given to patellofemoral instabili-
ty cases (Table 1: cases 2L, 3, 5 and also 11R). The only
case (Table 1: case 3) in which instability was the indi-
cation was also unstable after implantation of the device.
Apparently the constrained design was not enough to
s o l v e t h e s e p r e - e x i s t i n g p a t e l l o f e m o r a l
dislocation issues. Possibly the re-intervention (a re-
alignment) could have been prevented when a re-
alignment procedure was done at or before PFA implan-
tation. Our assumption that it is important to adequately
treat instability before PFA is highlighted by cases 20, 7L
and 7R (Table 1), in which a history of medialising tu-
berosity transfer osteotomies led to a good outcome after
PFA. In contrast, a Maquet procedure does not seem to
have the same effect. This is understandable because in
this procedure there is only advancement of the tuberos-
ity with no influence on stability.
The remaining instability cases (Table 1: cases 2L, 5 and
11R) had no previous history of instability. Either this was not
apparent at the time of surgery or there are surgeon-related
and/or implant-related factors that contributed to the post-
Fig. 2 Survival rate according to
loss of integrity of the prosthesis
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Table 1 Summary of case characteristics and procedures
Case Indication for PFA Previous surgery Indication for
further surgery
Type of further
surgery
Time after PFA Satisfaction
ratea
1R Secondary PFOA Maquetplasty MML Arthroscopy 5 years 5 months N/A
Arthroscopy (×2) MML Arthroscopy 6 years 5 months
Arthrotomy (×2) TFOA TKA 7 years
2L Idiopathic PFOA Arthroscopy; PFCM Subluxation TTOT + VMO 7 months 1
3 Patellofemoral dysplasia
with subluxation
– Patella luxation Rev. patellar
component
+ TTOT
3 months 2
4R Secondary PFOA Arthroscopic lateral
release
TFOA TKA 7 years 2 months N/A
5 Idiopathic PFOA Arthroscopy; MML Subluxation Rev. PFA 3 months N/A
Subluxation Rev. patellar
component
9 months
Subluxation Arthrotomy 3 years
Subluxation TKA 3 years 2 months
6 Post-traumatic PFOA Arthroscopy; PFCM,
post-op haemarthros
Stiffness MUA 10 days N/A
Pain Arthroscopy 1 month
Pain Rev. PFA 2 months
Haemarthros Arthrotomy 2 months 12 days
Persistent drainage Arthrotomy 2 months 17 days
Persistent infection Arthrodesis 5 years
1L Secondary PFOA Maquetplasty Medial pain Arthroscopy 5 years 2 months N/A
Arthroscopic
perichondiumplasty
TFOA TKA 5 years 7 months
8 Secondary PFOA Maquetplasty Stiffness MUA 16 days 2
Arthroscopy (×2); PFCM Stiffness Arthroscopy 7 years 4 months
9R Secondary PFOA Maquetplasty Pain Arthroscopy 11 years 1
Arthroscopy (×4);
PFCM, MML
Pain Rev. patellar
component
11 years 9 months
Pain Arthroscopy 12 years 9 months
9L Secondary PFOA Maquetplasty TFOA TKA + TTOT 5 years 8 months N/A
Arthroscopy (×3);
PFCM, MML
11L Idiopathic PFOA – TFOA TKA 7 years N/A
11R Idiopathic PFOA – Loosening Rev. patellar
component
1 year 6 months N/A
Infection after revision Extraction PFA 2 years 5 months
Infection after revision TKA 2 years 9 months
12 Idiopathic PFOA Arthroscopy; PFCM – – – 2
13 Secondary PFOA Arthrotomy; total
synovectomy
– – – 3
14 Idiopathic PFOA Arthroscopy; MML – – – 2
16 Idiopathic PFOA Arthroscopy; PFCM – – – 1
17 Idiopathic PFOA Arthroscopy; PFCM – – – 1
19 Idiopathic PFOA Arthroscopy; PFCM – – – 3
20 Secondary PFOA Trochleaosteotomy,
medialising TTOT
– – – 2
22 Idiopathic PFOA Arthroscopy; PFCM – – – 2
24 Idiopathic PFOA Arthroscopy; PFCM – – – Lost to FU
10 Idiopathic PFOA MCL reconstruction – – – 1
18R Idiopathic PFOA Arthroscopy; PFCM – – – 1
2R Idiopathic PFOA Arthroscopy; PFCM – – – 1
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operative problems in these cases. This underlines the impor-
tance of proper surgical technique and possibly also reflects
effects of low volume surgery. Cases 5 and 11R (Table 1)
illustrate that once tracking problems exist it is not easy to
resolve them by just revising a part of the complete prosthesis.
As for possible implant-specific related issues, the high
constrained design of the Richards’ II easily leads to assump-
tions that it is less sensitive to medio-lateral instability. But
you can also argue that in the pursuit of proper tracking there
is less freedom of play compared to the current more mobile,
less constraint designs. Hypothetically in this design, moder-
ate malalignment could lead to polyethylene (over)loading of
the (lateral) facet and trochlea shoulder leading to subsequent
wear and pain because of strain on the soft tissues and particle
disease. Observing the little to no polyethylene wear in con-
version cases up to 12 years after primary implantation,
overloading and wear did not seem to be a big issue in the
Richards’ II. Severe malalignment, however, could still lead to
luxation, even in this design. As was shown in case 3
(Table 1). In the literature, more and more emphasis is being
put on optimal implant positioning to achieve optimal track-
ing. Current designs use more sophisticated guiding in-
struments that mostly refer to the intramedullary femoral
canal, anterior cortex, mechanical tibial axis, femoral
epicondyles, direction of the native trochlea or a combination
of these. Some authors remind us of the added value of nav-
igation [10]. Most PFAs are based on TKA trochlea templates
and anterior femoral cuts (Bonlay^) or sinking the trochlea
shield into the native trochlea (Binlay^). These different
options and supporting philosophies allow for different
ways of implantation and positioning control [11], but
there is no consensus on what the optimal method or
position should be. In theory the amount of constraint
in the Richards’ II would make it less prone for implan-
tation errors; but it seems that no matter which direction
the patella is forced in, it will follow its own course. A
number of cases (e.g. cases 5 and 11R) illustrate this point.
The V-shaped patellabutton is a concern for some authors
because conversion to TKAmeans revising the patella as well
[12]. To our knowledge, there is no discussion if the patella
should be resurfaced or not in PFA, opposed to TKA [13, 14].
In any case, in our experience the patellabutton does not cause
problems in revision cases. It can be easily removed at the
level of the bone cement-polyethylene interface. The remain-
ing pegs can also be removed without effort. In all cases we
were left with a good bone surface to receive a new patellar
implant.
The ideal candidate for PFA, as proposed by Walker et al.
[15], should be 50–60 years old, in our cohort the average age
was 47.7 years, so not all our patients fit this profile. Also,
there where disproportionally more women (79 %) than men
(21 %), over-representing women.
A common re-operation was conversion to TKA because
of ongoing tibiofemoral osteoarthritis in the medial or lateral
compartment [4]. Seven of the 33 (21%) cases were converted
to TKA at an average time of 5.5 years after implanta-
tion; five of which were because of TFOA. The number
of conversions would probably be lower if we were able
Table 1 (continued)
Case Indication for PFA Previous surgery Indication for
further surgery
Type of further
surgery
Time after PFA Satisfaction
ratea
7L Secondary PFOA Maquetplasty
Medialising and
distalising TTOT
Arthroscopy; PFCM
– – – 1
7R Secondary PFOA Medialising and
distalising TTOT
– – – 1
Arthroscopy; PFCM
15 Idiopathic PFOA – – – – Lost to FU
18L Idiopathic PFOA – – – – 1
21L Idiopathic PFOA – – – – Lost to FU
21R Idiopathic PFOA – – – – Lost to FU
23L Idiopathic PFOA – – – – 1
23R Idiopathic PFOA – – – – 1
4L Idiopathic PFOA – – – – 1
FU follow-up, L left, R right,MMLmedial meniscal lesion,MUA manipulation under anaesthesia, N/A not applicable, PFA patellofemoral arthroplasty,
PFOA patellofemoral osteoarthritis, PFCM patellofemoral chondromalacia, Rev. revision, Secondary PFOA patellofemoral osteoarthritis due to
patellofemoral dysplasia and/or malalignment, TFOA tibiofemoral osteoarthritis, TKA total knee arthroplasty, TTOT tibial tuberosity osteotomy, VMO
vastus medialis oblique reeving
a As rated by the patient at time of FU: 1. Excellent, asymptomatic after PFA; 2. Good, improvement after PFA but not asymptomatic; 3. Fair, no change
after PFA; 4. Poor, worse after PFA
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to predict which patients develop ongoing osteoarthritis.
Presumably, in these patients signs of disease in other
compartments were present when the indication for PFA
was made, although not visible on X-rays. Pain in other
areas of the knee than anterior is highly suggestive and
should be investigated. Subclinical osteoarthritis can be-
come apparent on magnetic resonance imaging (MRI),
bone scintigraphy, single-photon emission computed to-
mography (SPECT) or arthroscopy [16–18], which can
help to establish a correct diagnosis. In any case, we
highly discourage using PFA in patients who show any symp-
toms of disease in other compartments than patellofemoral.
Patient selection, proper surgical technique, implant design
and positioning, as well as surgical volume, probably all
played a role in achieving the high operation rate in this
cohort.
Some potential limitations of the study have to be
discussed. First, although comparable to other studies, the
study sample is relatively small [4]. Second, we have a rela-
tively large number of bilateral cases (18 out of 33; 55 %).
Both the small sample and the large percentage of bilateral
cases may interfere with the survival analyses [19, 12, 20,
21]. Finally we did not use a PF specific questionnaire as in
other PF related studies [14]. Strength of this study is that it is
a single surgeon series.
In conclusion we found a 10-year survival of the Richards’
II PFA of 73 % (95 % CI, 57–93 %), which is comparable to
known data but does not seem to meet the ODEP criterion of
90 % survival at 10 years. Although re-operation rates are
slightly higher than those published by other groups so
are the satisfaction rates. We consider our results com-
parable to those reported in literature. According to cur-
rent standards, implantation of this particular design
should only be allowed in a controlled study environ-
ment. For this type of prosthesis, but we believe this
can be extrapolated to current PFA designs, patient se-
lection, proper surgical technique, implant design and
positioning are crucial to optimise outcome. Seventy-
one percent of the conversion-to-TKA cases were be-
cause of TFOA. We strongly suggest refraining from
the use of PFA in knees that show any sign of disease
in other compartments than patellofemoral.
A B
C D
F
Fig. 3 a–eA chronological series
of axial radiographs of case 5
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